4559 — Zeria Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual cashflow statement for Zeria Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,923	5,722	7,273	9,508	12,619
Depreciation
Amortisation
Non-Cash Items	-65.7	439	169	-1,702	-47.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,399	-2,481	-433	-3,178	-7,203
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,894	9,080	13,157	12,184	12,922
Capital Expenditures	-16,133	-1,421	-2,658	-3,899	-2,734
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,328	-1,472	83.2	-53.6	1,683
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-17,461	-2,893	-2,575	-3,952	-1,051
Financing Cash Flow Items	-3.23	-3.52	-3.93	-1.49	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11,185	-4,841	-7,415	-8,124	-7,757
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	789	1,910	4,515	2,510	4,864